Indoco’s AnaCipher CRO clears US FDA inspection with Zero 483s
The CRO, located in Hyderabad, was inspected by the FDA from 12th to 16th September, 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indoco Remedies
Indoco launches initiative to promote green energy
This is in compliance with the regulatory requirement for being a ‘captive user’, under the Indian Electricity laws
Indoco’s PAT jumps 62 per cent in Q4FY22
For the year ending March 22, the revenues grew by 23.4 per cent at Rs 1502.7 crores, as against Rs 1217.4 crores, same period…
Indoco Remedies gets final nod from US FDA for Lacosamide tablet
The approval granted by the US Food and Drug Administration (FDA) for Lacosamide tablets is for strengths of 50 mg, 100 mg, 150 mg…
Indoco’s CRO AnaCipher receives UKMHRA accreditation
A virtual inspection was carried out from 4th to 7th May and 10th to 11th May, 2021
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma
It is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma
Indoco launches favipiravir 400 mg tablets
Fevindo - 400 will be made available at all government approved COVID care centres and selected medical practitioners across the…
Indoco gets USFDA approval for Olanzapine tablets
Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
Indoco announces Q4FY20 financial results; revenues stand at Rs 263 Crores
The company recorded a net profit of Rs 5.4 crores, as against Rs 11.6 crores, same quarter last year
Indoco receives US FDA approval for Succinylcholine Chloride Injection USP
Succinylcholine Chloride Injection is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to…